In a report released on August 28, Josh Siegler from Cantor Fitzgerald reiterated a Hold rating on Mawson Infrastructure Group (MIGI – Research Report), with a price target of $1.00. The company’s shares closed yesterday at $0.74.
According to TipRanks, Siegler is an analyst with an average return of -11.4% and a 40.91% success rate. Siegler covers the Technology sector, focusing on stocks such as Riot Platforms, TeraWulf Inc, and Root.
Currently, the analyst consensus on Mawson Infrastructure Group is a Moderate Buy with an average price target of $2.00.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $5.22 and a one-year low of $0.43. Currently, Mawson Infrastructure Group has an average volume of 161.1K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Wize Pharma, Inc. develops, produces and sells electronic and electro-optical systems. It focuses on treatment of ophthalmic disorders including Dry Eye Syndrome and other inflammatory conditions. The company holds rights to purchase, market, sell and distribute LO2A. Wize Pharma is headquartered in Hod Hasharon, Israel.
Read More on MIGI:
- Here’s What You Missed in Crypto This Week
- Mawson downgraded to Neutral from Overweight at Cantor Fitzgerald
- Mawson Infrastructure reports July revenue in BTC at 163, up 23% from June
- Mawson Infrastructure reports Q2 revenue $10.6M, up 38% from Q1
- Mawson Infrastructure reports June self-mining Bitcoin production of 71
